The efficacy and safety of Shugan Wendan Decoction in the treatment of metabolic syndrome: a randomized controlled clinical trial
- Conditions
- Metabolic syndrome
- Registration Number
- ITMCTR2100004676
- Lead Sponsor
- The Second Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine (Guangdong Provincial Hospital of Traditional Chi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- Not specified
(1) Meet the diagnostic criteria of metabolic syndrome
(2) It accords with the mutual accumulation of phlegm and blood stasis, and also clamps the syndrome of stagnation of the liver;
(3) Aged between 18-75 years old;
(4) Those who voluntarily sign the informed consent.
(1) Patients with severe cardiovascular and cerebrovascular diseases (such as cardiac insufficiency, acute myocardial infarction, cerebral infarction, cerebral hemorrhage, etc.), liver and kidney insufficiency, mental disorders and other diseases; patients with severe complications such as type I diabetes or diabetic ketosis;
(2) Those who are unwilling to cooperate with data collection and blood sampling;
(3) Women during pregnancy or lactation;
(4) Those who use insulin to control blood sugar
(5) Other situations that the researcher thinks are not suitable for participating in this research.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Blood lipids;
- Secondary Outcome Measures
Name Time Method TCM Syndrome Points;Insulin resistance index;Fasting blood glucose;Fasting insulin;Glycated hemoglobin;